Literature DB >> 12086312

Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis.

R Holmdahl1, J C Lorentzen, S Lu, P Olofsson, L Wester, J Holmberg, U Pettersson.   

Abstract

Rat models are useful for studies of the pathogenesis of rheumatoid arthritis (RA) since rats are extraordinarily sensitive to induction of arthritis with adjuvants. Injection of not only the classical complete Freund's adjuvant but also mineral oil without mycobacteria and pure adjuvants such as pristane and squalene, induce severe arthritis in many rat strains. Models like pristane-induced arthritis in rats are optimal models for RA since they fulfill the RA criteria including a chronic relapsing disease course. Arthritogenic adjuvants like pristane, avridine, squalene and mineral oil are not immunogenic since they do not contain major histocompatibility complex (MHC) binding peptides. Nevertheless, the diseases are MHC-associated and dependent on the activation of alphabetaTCR (T-cell receptor)-expressing T cells. However, it has not been possible to link the immune response to joint antigens or other endogenous components although immunization with various cartilage proteins induce arthritis but with different pathogeneses. To unravel the mechanisms behind adjuvant-induced arthritis, a disease-oriented genetic approach is optimal. Several loci that control onset of arthritis, severity and chronicity of the disease have been identified in genetic crosses and most of these have been confirmed in congenic strains. In addition, many of these loci are found in other autoimmune models in the rat as well as associated with arthritis in mice and humans.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12086312     DOI: 10.1034/j.1600-065x.2001.1840117.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  59 in total

1.  The arthritogenic adjuvant squalene does not accumulate in joints, but gives rise to pathogenic cells in both draining and non-draining lymph nodes.

Authors:  B C Holm; L Svelander; A Bucht; J C Lorentzen
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

2.  Generating gene knockout rats by homologous recombination in embryonic stem cells.

Authors:  Chang Tong; Guanyi Huang; Charles Ashton; Ping Li; Qi-Long Ying
Journal:  Nat Protoc       Date:  2011-05-26       Impact factor: 13.491

3.  Anti-arthritic effects of FasL gene transferred intra-articularly by an inducible lentiviral vector containing improved tet-on system.

Authors:  Qingyu Shi; Xuebi Tian; Yinlin Zhao; Huiyu Luo; Yuke Tian; Ailin Luo
Journal:  Rheumatol Int       Date:  2011-07-27       Impact factor: 2.631

4.  Sensory and vascular changes in a rat monoarthritis model: prophylactic and therapeutic effects of meloxicam.

Authors:  Javeria Ali Hashmi; Kiran Yashpal; David W Holdsworth; James L Henry
Journal:  Inflamm Res       Date:  2010-03-28       Impact factor: 4.575

5.  [Pain measurement in animal models].

Authors:  M Busch-Dienstfertig; C Stein
Journal:  Z Rheumatol       Date:  2013-03       Impact factor: 1.372

6.  Gait changes precede overt arthritis and strongly correlate with symptoms and histopathological events in pristane-induced arthritis.

Authors:  Markus H Hoffmann; Rudolf Hopf; Birgit Niederreiter; Heinz Redl; Josef S Smolen; Günter Steiner
Journal:  Arthritis Res Ther       Date:  2010-03-11       Impact factor: 5.156

7.  Housekeeping gene stability in pristane-induced arthritis and antigen-induced pulmonary inflammation of rats.

Authors:  Congshan Jiang; Liesu Meng; Wenhua Zhu; Muhammad Shahzad; Xudong Yang; Shemin Lu
Journal:  Inflamm Res       Date:  2009-04-09       Impact factor: 4.575

8.  BALB/c mice genetically susceptible to proteoglycan-induced arthritis and spondylitis show colony-dependent differences in disease penetrance.

Authors:  Balint Farkas; Ferenc Boldizsar; Oktavia Tarjanyi; Anna Laszlo; Simon M Lin; Gabor Hutas; Beata Tryniszewska; Aaron Mangold; Gyorgy Nagyeri; Holly L Rosenzweig; Alison Finnegan; Katalin Mikecz; Tibor T Glant
Journal:  Arthritis Res Ther       Date:  2009-02-16       Impact factor: 5.156

9.  Acid-mediated reactions under microfluidic conditions: a new strategy for practical synthesis of biofunctional natural products.

Authors:  Katsunori Tanaka; Koichi Fukase
Journal:  Beilstein J Org Chem       Date:  2009-08-20       Impact factor: 2.883

Review 10.  Lessons from animal models of arthritis over the past decade.

Authors:  Wim B van den Berg
Journal:  Arthritis Res Ther       Date:  2009-10-14       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.